Tailoring axillary treatment in patients with hormone receptor positive breast cancer treated with neo-adjuvant endocrine therapy
European Journal of Cancer · 2026-03 · 237 · 116493
DOI: 10.1016/j.ejca.2026.116493 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Cancer, 2026-03. Verfasst von A. Beerthuizen und 5 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Beerthuizen, A., Snellen, T., Drukker, C., Scholten, A., Duijnhoven, F. V., & Peeters, M. V. (2026). Tailoring axillary treatment in patients with hormone receptor positive breast cancer treated with neo-adjuvant endocrine therapy. European Journal of Cancer, 237, 116493. https://doi.org/10.1016/j.ejca.2026.116493
Vancouver
Beerthuizen A, Snellen T, Drukker C, Scholten A, Duijnhoven FV, Peeters MV. Tailoring axillary treatment in patients with hormone receptor positive breast cancer treated with neo-adjuvant endocrine therapy. European Journal of Cancer. 2026;237:116493. doi:10.1016/j.ejca.2026.116493
BibTeX
@article{Beerthuizen2026,
author = {Beerthuizen, A. and Snellen, T. and Drukker, C. and Scholten, A. and Duijnhoven, F. van and Peeters, M.J. Vrancken},
title = {Tailoring axillary treatment in patients with hormone receptor positive breast cancer treated with neo-adjuvant endocrine therapy},
journal = {European Journal of Cancer},
year = {2026},
volume = {237},
pages = {116493},
doi = {10.1016/j.ejca.2026.116493}
}
EUVIMED